Cargando…
Economic Evaluation of Dulaglutide vs Traditional Therapies: Implications of the Outcomes of the Rewind Study
BACKGROUND: Diabetes represents a relevant public health problem worldwide due to its growing prevalence and socioeconomic burden, principally due to the development of macrovascular and microvascular complications as well as to the continuous launch of new and even more expensive drugs. The aim of...
Autores principales: | Torre, Enrico, Bruno, Giacomo M, Di Matteo, Sergio, Martinotti, Chiara, Valentino, Maria Chiara, Bottaro, Luigi C, Colombo, Giorgio L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7152542/ https://www.ncbi.nlm.nih.gov/pubmed/32308446 http://dx.doi.org/10.2147/CEOR.S240183 |
Ejemplares similares
-
Cost-Utility Analysis of Saxagliptin/Dapagliflozin Versus Gliclazide
and Insulin Glargine: Economic Implications of the Outcomes of the CVD-Real
Studies I and II
por: Torre, Enrico, et al.
Publicado: (2020) -
Cost-minimization analysis of degludec/liraglutide versus glargine/aspart: economic implications of the DUAL VII study outcomes
por: Torre, Enrico, et al.
Publicado: (2018) -
Economic Burden of Non-Alcoholic Steatohepatitis (NASH) Among Diabetic Population in Italy: Analysis and Perspectives
por: Torre, Enrico, et al.
Publicado: (2022) -
OR30-06 Assessment of Dulaglutide Safety in Older Patient Populations in Rewind
por: Konig, Manige, et al.
Publicado: (2020) -
Efficacy and Safety of Dulaglutide in Older Patients: A post hoc Analysis of the REWIND trial
por: Riddle, Matthew C, et al.
Publicado: (2021)